1. Piotukh K, Gu W, Kofler M, Labudde D, Helms V, Freund C. Cyclophilin A binds to linear peptide motifs containing a consensus that is present in many human proteins. J Biol Chem. 2005;280(25):23668-74. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
2. Zydowsky LD, Etzkorn FA, Chang HY, Ferguson SB, Stolz LA, Ho SI, et al. Active site mutants of human cyclophilin A separate peptidyl‐prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci. 1992;1(9):1092-9. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
3. Nigro P, Pompilio G, Capogrossi MC. Cyclophilin A: A key player for human disease. Cell Death Dis. 2013;4(10). [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
4. Hopkins S, Dimassimo B, Rusnak P, Heuman D, Lalezari J, Sluder A, et al. The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection. J Hepatol. 2012;57(1):47-54. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
5. Hopkins S, Bobardt M, Chatterji U, Garcia-Rivera JA, Lim P, Gallay PA. The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin a complexes. Antimicrob
Agents Chemother. 2012;56(7):3888-97. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
6. Hopkins S, Scorneaux B, Huang Z, Murray MG, Wring S, Smitley C, et al. SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of Hepatitis C virus RNA replication in vitro. Antimicrob Agents Chemother. 2010;54(2):660-72. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
7. Ahmed-Belkacem A, Colliandre L, Ahnou N, Nevers Q, Gelin M, Bessin Y, et al. Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities. Nat Commun. 2016;7. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
8. Naoumov N V. Cyclophilin inhibition as potential therapy for liver diseases. J Hepatol. 2014;61(5):1166-74. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
9. Mohebbi A, Mohammadi S, Memarian A. Prediction of HBF-0259 interactions with hepatitis B Virus receptors and surface antigen secretory factors. VirusDisease. 2016;27(3):234-41. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
10. Śledź P, Caflisch A. Protein structure-based drug design: from docking to molecular dynamics. Curr Opin Struct Biol. 2018;48:93-102. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
11. Lv M, Shi T, Mao X, Li X, Chen Y, Zhu J, et al. 1-(2,6-Dibenzyloxybenzoyl)-3-(9H-fluoren-9-yl)-urea: A novel cyclophilin A allosteric activator. Biochem Biophys Res Commun. 2012;425(4):938-43. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
12. Ivery MTG. A proposed molecular model for the interaction of calcineurin with the cyclosporin A-Cyclophilin a complex. Bioorganic Med Chem. 1999;7(7):1389-402. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
13. Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, et al. The protein data bank. Acta Crystallogr Sect D Biol Crystallogr. 2002;58(6 I):899-907. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
14. Kallen J, Mikol V, Taylor P, D.walkinshaw M. X-ray structures and analysis of 11 cyclosporin derivatives complexed with cyclophilin A. J Mol Biol. 1998;283(2):435-49. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
15. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera - A visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605-12. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
16. Bolton EE, Wang Y, Thiessen PA, Bryant SH. Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities. Annu Rep Comput Chem. 2008;4:217-41. [
View at Publisher] [
DOI] [
Google Scholar]
17. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis. 1997;18(15):2714-23. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
18. Chase F, Avenue B. Rotamer libraries in the 21 st century Roland L Dunbrack Jr. Proteins [Internet]. 2002;12(4):431-40. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0959440X02003445 [
View at Publisher] [
DOI] [
Google Scholar]
19. Najmanovich R, Kuttner J, Sobolev V, Edelman M. Side-chain flexibility in proteins upon ligand binding. Proteins Struct Funct Genet. 2000;39(3):261-8.
https://doi.org/10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO;2-4 [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
20. Liu J, Chen CM, Walsh CT. Human and Escherichia coli Cyclophilins: Sensitivity to Inhibition by the Immunosuppressant Cyclosporin A Correlates with a Specific Tryptophan Residue. Biochemistry. 1991;30(9):2306-10. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
21. Allouche A. Software News and Updates Gabedit - A Graphical User Interface for Computational Chemistry Softwares. J Comput Chem. 2012;32:174-82. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
22. Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, et al. Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19-25. [
View at Publisher] [
DOI] [
Google Scholar]
23. Oostenbrink C, Villa A, Mark AE, Van Gunsteren WF. A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem. 2004;25(13):1656-76. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
24. Schüttelkopf AW, Van Aalten DMF. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr Sect D Biol Crystallogr. 2004;60(8):1355-63. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
25. Ihaka R, Gentleman R. R: A Language for Data Analysis and Graphics. J Comput Graph Stat. 1996;5(3):299-314. [
View at Publisher] [
DOI] [
Google Scholar]
26. jIhaka R, Gentleman R. R: A Language for Data Analysis and Graphics. J Comput Graph Stat. 1996;5(3):299-314. [
View at Publisher] [
DOI] [
Google Scholar]
27. McGowan LC, Hamelberg D. Conformational plasticity of an enzyme during catalysis: Intricate coupling between cyclophilin a dynamics and substrate turnover. Biophys J. 2013;104(1):216-26. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
28. Sargsyan K, Grauffel C, Lim C. How Molecular Size Impacts RMSD Applications in Molecular Dynamics Simulations. J Chem Theory Comput. 2017;13(4):1518-24. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
29. Dietrich L, Ehrlich LS, LaGrassa TJ, Ebbets-Reed D, Carter C. Structural Consequences of Cyclophilin A Binding on Maturational Refolding in Human Immunodeficiency Virus Type 1 Capsid Protein. J Virol. 2001;75(10):4721-33. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
30. Lammers M, Neumann H, Chin JW, James LC. Acetylation regulates Cyclophilin A catalysis, immunosuppression and HIV isomerization. Nat Chem Biol. 2010;6(5):331-7. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
31. Chatterji U, Bobardt M, Selvarajah S, Yang F, Tang H, Sakamoto N, et al. The isomerase active site of cyclophilin A is critical for hepatitis C virus replication. J Biol Chem. 2009;284(25):16998-7005. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
32. Ciccone DS, Natelson BH. Comorbid illness in women with chronic fatigue syndrome: A test of the single syndrome hypothesis. Psychosom Med. 2003;65(2):268-75. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
33. Hamelberg D, Mecammon JA. Mechanistic insight into the role of transition-state stabilization in cyclophilin A. J Am Chem Soc. 2009;131(1):147-52. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
34. Ladani ST, Hamelberg D. Entropic and surprisingly small intramolecular polarization effects in the mechanism of cyclophilin A. J Phys Chem B. 2012;116(35):10771-8. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]